- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.55 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x N5H: (2~{E},5~{R},10~{E},12~{E},15~{S},19~{R})-20-[[(2~{R},3~{R})-3-aminocarbonyloxy-2-methyl-butanoyl]amino]-3,5,15-trimethyl-7-methylidene-19-oxidanyl-17-oxidanylidene-icosa-2,10,12-trienoic acid(Non-covalent)
N5H.2: 17 residues within 4Å:- Chain A: R.45, A.100, F.101, A.102, M.104, Y.152, V.159, Q.160, Y.162, M.165, L.201, S.202, A.203, V.206, F.209, I.212
- Ligands: NDP.1
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:A.100, A:Y.152, A:Y.152, A:V.159, A:Y.162, A:Y.162, A:L.201, A:A.203, A:V.206, A:F.209, A:F.209, A:I.212
- Hydrogen bonds: A:R.45, A:A.100, A:A.102, A:A.102, A:M.104
- Salt bridges: A:K.169
N5H.4: 17 residues within 4Å:- Chain B: A.100, F.101, A.102, M.104, L.107, Y.152, V.159, Q.160, N.161, Y.162, M.165, L.201, S.202, A.203, V.206, I.212
- Ligands: NDP.3
15 PLIP interactions:15 interactions with chain B- Hydrophobic interactions: B:A.100, B:L.107, B:V.159, B:Y.162, B:L.201, B:A.203, B:V.206, B:V.206, B:I.212
- Hydrogen bonds: B:A.100, B:A.102, B:A.102, B:M.104, B:Y.162
- Salt bridges: B:K.169
N5H.6: 16 residues within 4Å:- Chain C: A.100, F.101, A.102, M.104, L.107, Y.152, V.159, Q.160, Y.162, M.165, L.201, S.202, A.203, V.206, I.212
- Ligands: NDP.5
15 PLIP interactions:15 interactions with chain C- Hydrophobic interactions: C:A.100, C:L.107, C:Y.152, C:V.159, C:Y.162, C:L.201, C:A.203, C:V.206, C:I.212
- Hydrogen bonds: C:A.102, C:A.102, C:M.104, C:Y.162, C:S.202
- Salt bridges: C:K.169
N5H.8: 17 residues within 4Å:- Chain D: R.48, A.100, F.101, A.102, M.104, L.107, Y.152, V.159, Q.160, Y.162, M.165, S.202, A.203, V.206, F.209, I.212
- Ligands: NDP.7
14 PLIP interactions:14 interactions with chain D- Hydrophobic interactions: D:A.100, D:L.107, D:Y.152, D:V.159, D:Y.162, D:A.203, D:V.206, D:F.209, D:F.209, D:I.212
- Hydrogen bonds: D:A.100, D:A.102, D:A.102, D:M.104
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fage, C.D. et al., The Kalimantacin Polyketide Antibiotics Inhibit Fatty Acid Biosynthesis in Staphylococcus aureus by Targeting the Enoyl-Acyl Carrier Protein Binding Site of FabI. Angew.Chem.Int.Ed.Engl. (2020)
- Release Date
- 2020-04-01
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.55 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x N5H: (2~{E},5~{R},10~{E},12~{E},15~{S},19~{R})-20-[[(2~{R},3~{R})-3-aminocarbonyloxy-2-methyl-butanoyl]amino]-3,5,15-trimethyl-7-methylidene-19-oxidanyl-17-oxidanylidene-icosa-2,10,12-trienoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fage, C.D. et al., The Kalimantacin Polyketide Antibiotics Inhibit Fatty Acid Biosynthesis in Staphylococcus aureus by Targeting the Enoyl-Acyl Carrier Protein Binding Site of FabI. Angew.Chem.Int.Ed.Engl. (2020)
- Release Date
- 2020-04-01
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H